Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis

Increasing numbers of admissions for sepsis impose a heavy burden on health care systems worldwide, while novel therapies have proven both expensive and ineffective. We explored the long-term mortality and hospitalization costs after adjunctive therapy with intravenous clarithromycin in ventilator-a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Tsaganos, Thomas, Raftogiannis, Maria, Pratikaki, Maria, Christodoulou, Sofia, Kotanidou, Anastasia, Papadomichelakis, Evangelos, Armaganidis, Apostolos, Routsi, Christina, Giamarellos-Bourboulis, Evangelos J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879428/
https://ncbi.nlm.nih.gov/pubmed/27044546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02974-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados